oleanolic acid has been researched along with ADPKD in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Capolongo, G; Celentano, S; Pollastro, RM | 1 |
Chen, M; Fu, L; Gu, J; Liu, D; Lv, J; Mei, C; Shi, W; Song, S; Sun, K; Xu, D; Xue, C; Yang, B; Zhou, W | 1 |
1 review(s) available for oleanolic acid and ADPKD
Article | Year |
---|---|
[Bardoxolone: a new potential therapeutic agent in the treatment of autosomal dominant polycystic kidney disease?]
Topics: Clinical Trials as Topic; Disease Progression; Down-Regulation; Early Termination of Clinical Trials; Glomerular Filtration Rate; Heart Failure; Humans; Kidney Failure, Chronic; NF-E2-Related Factor 2; NF-kappa B; Oleanolic Acid; Polycystic Kidney, Autosomal Dominant; Renal Agents | 2019 |
1 other study(ies) available for oleanolic acid and ADPKD
Article | Year |
---|---|
Saikosaponin-d inhibits proliferation by up-regulating autophagy via the CaMKKβ-AMPK-mTOR pathway in ADPKD cells.
Topics: AMP-Activated Protein Kinases; Autophagy; Calcium-Calmodulin-Dependent Protein Kinase Kinase; Cell Line, Transformed; Cell Proliferation; Gene Expression Regulation, Enzymologic; Humans; Oleanolic Acid; Polycystic Kidney, Autosomal Dominant; Saponins; Signal Transduction; TOR Serine-Threonine Kinases | 2018 |